Clinical Trials Browser

Terminated × Interventional × andecaliximab × Clear all

NCT02862535 2020-12-24

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 1 Terminated

36 enrolled 17 charts

Gastrointestinal

Gastric Adenocarcinoma

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Phase 2 Terminated

15 enrolled 11 charts

Arthritis, Rheumatoid